Events & Presentations

Presentations

Upcoming Events

There are currently no events to display.

Archived Events

Summary Toggle
May 21,2019 11:00 AM EDT
RBC Capital Markets Healthcare Conference
Summary Toggle
May 20,2019 1:00 PM EDT
UBS Global Healthcare Conference
Summary Toggle
May 06,2019 4:30 PM EDT
Arbutus Biopharma Corporation 2019 First Quarter Financial Results and Corporate Update
Summary Toggle
Mar 11,2019 2:50 PM EDT
Cowen and Company 39th Annual Healthcare Conference
Summary Toggle
Mar 07,2019 1:30 PM PST
Arbutus Biopharma Corporation Fourth Quarter and Year End 2018 Financial Results and Corporate Update
Summary Toggle
Nov 07,2018 4:30 PM EST
Arbutus Biopharma Corporation 2018 Third Quarter Financial Results and Corporate Update
Summary Toggle
Oct 09,2018 2:45 PM EDT
Chardan 2nd Annual Genetic Medicines Conference
Summary Toggle
Oct 03 - 06,2018
International HBV Meeting
Summary Toggle
Sep 25,2018
Antivirals: Targeting HBV and Beyond

Supporting Materials

Summary Toggle
Sep 04,2018 9:50 AM EDT
B. Riley FBR Healthcare Conference
Summary Toggle
Aug 15,2018 2:30 PM EDT
2018 Wedbush PacGrow Healthcare Conference
Summary Toggle
Aug 02,2018 4:30 PM EDT
Arbutus to Report Second Quarter 2018 Financial Results
Summary Toggle
Jul 10,2018 4:00 PM EDT
Roivant Pipeline Day
Summary Toggle
May 03,2018 1:30 PM PDT
Arbutus Biopharma Corporation 2018 First Quarter Financial Results and Corporate Update
Additional Information
Arbutus would like to correct a misspeak by Koert VandenEnden in this archived webcast. At 14:50, when Mr. VandenEnden said “Arbutus’ net loss for Q1 2018 was $15.7 million ($0.33 per common share),” he meant to say, “Arbutus’ net loss for Q1 2018 was $17.9 million ($0.36 per common share).
Summary Toggle
Apr 12,2018
Summary Toggle
Mar 14,2018 1:30 PM PDT
Arbutus Biopharma Corporation 2017 Fourth Quarter Financial Results and Corporate Update
Summary Toggle
Dec 06,2017 3:00 PM PST
Summary Toggle
Oct 22,2017
Summary Toggle
Oct 10,2017
Chardan Inaugural Gene Therapy Conference
Summary Toggle
Sep 25,2017
Summary Toggle
Sep 12,2017 1:00 PM EDT
LNP: Delivering mRNA Therapeutics to the Clinic

Supporting Materials

Summary Toggle
May 24,2017
AGM Proxy Statement
Additional Information
IMPORTANT NOTICE REGARDING THE AVAILABILITY OF PROXY MATERIALS FOR THE 2017 ANNUAL GENERAL MEETING OF SHAREHOLDERS TO BE HELD ON WEDNESDAY, MAY 24, 2017
 
This Notice of the 2017 Annual General Meeting of Shareholders, the Management Proxy Circular and Proxy Statement, and our Annual Report on Form 10-K for the Fiscal Year Ended December 31, 2016 are available at   http://investor.arbutusbio.com/financials.cfm
Summary Toggle
May 22,2017
Summary Toggle
Apr 22,2017
Summary Toggle
Dec 12,2016 1:30 PM PST
Arbutus Biopharma Corporation Conference Call

Supporting Materials

Summary Toggle
Nov 11 - 14,2016
Summary Toggle
Sep 29,2016 2:00 PM PDT
Arbutus Biopharma HBV Product Pipeline Update
Summary Toggle
Jul 17 - 20,2016
2016 Controlled Release Society Conference
Summary Toggle
Jun 01 - 02,2016
5th Antiviral Drugs Research and Development Conference

Supporting Materials

Summary Toggle
Apr 22,2016
11th Annual Drug Discovery Chemistry Conference

Supporting Materials

Summary Toggle
Apr 14,2016
Summary Toggle
Nov 17,2015